Amber Tate
Psychiatric/Mental Health · Midlothian, VANPI 1043763410
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 596 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 596 payments — averaging $21.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Otsuka America Pharmaceutical, Inc.$2K
- Neurocrine Biosciences, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Alkermes, Inc.$901
- Corium, LLC$859
- plus $5K from 18 others
What the payments were for
- Food & beverage$12,94399%
- Education$701%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 118 | $1,899 |
| Otsuka America Pharmaceutical, Inc. | 61 | $1,892 |
| Neurocrine Biosciences, Inc. | 33 | $1,459 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 65 | $1,387 |
| Alkermes, Inc. | 45 | $901 |
| Corium, LLC | 64 | $859 |
| Lundbeck LLC | 41 | $719 |
| Takeda Pharmaceuticals U.S.A., Inc. | 50 | $706 |
| Teva Pharmaceuticals USA, Inc. | 10 | $675 |
| Johnson & Johnson | 13 | $546 |
| Sunovion Pharmaceuticals Inc. | 28 | $423 |
| E.r. Squibb & Sons, L.L.C. | 3 | $342 |
| Supernus Pharmaceuticals, Inc. | 15 | $265 |
| Tris Pharma Inc | 11 | $203 |
| Collegium Pharmaceutical, Inc. | 8 | $162 |
| Axsome Therapeutics, Inc. | 6 | $135 |
| Ironshore Pharmaceuticals Inc. | 6 | $109 |
| Neos Therapeutics, LP | 5 | $78 |
| Avanir Pharmaceuticals, Inc. | 4 | $71 |
| Tempus AI, Inc | 1 | $67 |
| Idorsia Pharmaceuticals US Inc | 4 | $52 |
| Jazz Pharmaceuticals Inc. | 3 | $38 |
| Biogen | 1 | $16 |
| Eisai Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$950
- CAPLYTA$695
- REXULTI$583
- ABILIFY MAINTENA$469
- VRAYLAR$468
- COBENFY$258
- Azstarys$242
- ABILIFY ASIMTUFII$242
- Austedo XR$242
- UZEDY$239
- AUSTEDO$127
- Quillichew ER$122
- Dyanavel XR$122
- Quillivant$122
- INVEGA SUSTENNA$106
How this compares
$13,013 in reported general payments places this provider in the 95th percentile of 1,003 psychiatric/mental health providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 11 | $292 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $102 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Midlothian
- Donna ClarkeMidlothian$10K
- Justin RayChesapeake$127K
- Katia HallChesapeake$88K
- Christine GilmoreBedford$75K
- Sarah FaberNewport News$59K
- Kristine GarciaGlen Allen$46K
- Tonjanika BoydRichmond$40K
- Kirby PatmonRichmond$36K
- Juliana FroschAmherst$36K
- Derick ReedyNickelsville$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.